TokenPost·
Pfizer Announces Starna CAR-T Licensing Deal Worth Up to $2.6 Billion

The exclusive agreement covers development and commercialization of chimeric antigen receptor T-cell therapies.
Every crypto headline. One feed. Updated every minute.

The exclusive agreement covers development and commercialization of chimeric antigen receptor T-cell therapies.